×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SPRY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/11
12:43 pm
spry
ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines [Seeking Alpha]
Medium
Report
ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines [Seeking Alpha]
3/10
10:09 am
spry
ARS Pharmaceuticals (SPRY) was given a new $26.00 price target by Leerink Partners.
Medium
Report
ARS Pharmaceuticals (SPRY) was given a new $26.00 price target by Leerink Partners.
3/9
05:25 pm
spry
ARS Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
3/9
03:07 pm
spry
ARS Pharmaceuticals Inc (SPRY) Q4 2025 Earnings Call Highlights: Strong Market Entry and ... [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals Inc (SPRY) Q4 2025 Earnings Call Highlights: Strong Market Entry and ... [Yahoo! Finance]
3/9
09:22 am
spry
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
Medium
Report
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
3/9
06:39 am
spry
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization [Yahoo! Finance]
3/9
06:08 am
spry
ARS Pharmaceuticals GAAP EPS of -$1.74 beats by $0.02, revenue of $84.28M beats by $2.6M [Seeking Alpha]
Low
Report
ARS Pharmaceuticals GAAP EPS of -$1.74 beats by $0.02, revenue of $84.28M beats by $2.6M [Seeking Alpha]
3/9
06:00 am
spry
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
Low
Report
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
Date
Time
Symbol
Company Name
Action
%Chg
3/9/2026
06:00 am
SPRY
ars pharmaceuticals, inc.
IN-LINE
Report
-0.3%
ars pharmaceuticals, inc.
11/10/2025
06:00 am
SPRY
ars pharmaceuticals, inc.
MISS
Report
-1.1%
ars pharmaceuticals, inc.
8/13/2025
07:00 am
SPRY
ars pharmaceuticals, inc.
MISS
Report
-9.9%
ars pharmaceuticals, inc.
5/14/2025
07:00 am
SPRY
ars pharmaceuticals, inc.
IN-LINE
Report
-9.8%
ars pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/9
06:08 am
spry
Form 10-K ARS Pharmaceuticals, For: Dec 31
Low
Report
Form 10-K ARS Pharmaceuticals, For: Dec 31
3/9
06:03 am
spry
Form 8-K ARS Pharmaceuticals, For: Mar 09
Low
Report
Form 8-K ARS Pharmaceuticals, For: Mar 09
2/13
04:25 pm
spry
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: Rubric Capital Management LP
Medium
Report
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: Rubric Capital Management LP
1/21
12:32 pm
spry
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: BlackRock, Inc.
Medium
Report
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: BlackRock, Inc.
1/5
04:28 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Scott Kathleen D.
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Scott Kathleen D.
1/5
04:27 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Karas Eric
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Karas Eric
1/5
04:25 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Fitzpatrick Alexander A
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Fitzpatrick Alexander A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: